Clinical trial
Risk of COVID-19 Infection After Vaccination: A Nationwide Study Comparing BNT162b2, mRNA-1273 and ChAdOx1
NCT04848441 is registered in ClinicalTrials.gov with Umeå University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk of COVID-19 Infection After Vaccination: A Nationwide Study Comparing BNT162b2, mRNA-1273 and ChAdOx1
- Lead sponsor
- Umeå University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2021
- Completion date
- August 1, 2021
- Enrollment
- 2,000,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, vaccination; infection